DPP4 and Wilson disease: To summarize, the current investigation demonstrates that DPP-4 inhibition prevents abnormal increases in vascular stiffness, aortic fibrosis, oxidative stress and FGF-23/Klotho expression induced by a WD in female mice and these benefits occur independent of AGE reduction.